210 related articles for article (PubMed ID: 23519426)
21. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
Thakur A; Kaur H; Kaur S
Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
[TBL] [Abstract][Full Text] [Related]
22. Synergic effect of eugenol oleate with amphotericin B augments anti-leishmanial immune response in experimental visceral leishmaniasis in vitro and in vivo.
Kar A; Jayaraman A; Charan Raja MR; Srinivasan S; Debnath J; Mahapatra SK
Int Immunopharmacol; 2021 Feb; 91():107291. PubMed ID: 33360084
[TBL] [Abstract][Full Text] [Related]
23. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
Sane SA; Shakya N; Haq W; Gupta S
J Antimicrob Chemother; 2010 Jul; 65(7):1448-54. PubMed ID: 20495208
[TBL] [Abstract][Full Text] [Related]
24. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis.
Thakur A; Kaur H; Kaur S
Med Microbiol Immunol; 2015 Aug; 204(4):539-50. PubMed ID: 25432859
[TBL] [Abstract][Full Text] [Related]
26. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
27. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
Das P; Paik D; Naskar K; Chakraborti T
Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
[TBL] [Abstract][Full Text] [Related]
28. Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.
Murray HW; Hariprashad J; Coffman RL
J Exp Med; 1997 Mar; 185(5):867-74. PubMed ID: 9120392
[TBL] [Abstract][Full Text] [Related]
29. Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs.
Gogulamudi VR; Dubey ML; Kaul D; Hubert DJ; Kandimalla R; Sehgal R
Sci Rep; 2019 Jun; 9(1):8531. PubMed ID: 31189939
[TBL] [Abstract][Full Text] [Related]
30. A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice.
Malik F; Singh J; Khajuria A; Suri KA; Satti NK; Singh S; Kaul MK; Kumar A; Bhatia A; Qazi GN
Life Sci; 2007 Mar; 80(16):1525-38. PubMed ID: 17336338
[TBL] [Abstract][Full Text] [Related]
31. Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.
Freitas EO; Nico D; Alves-Silva MV; Morrot A; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004297. PubMed ID: 26701750
[TBL] [Abstract][Full Text] [Related]
32. Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv.
Shakya N; Sane SA; Vishwakarma P; Bajpai P; Gupta S
Acta Trop; 2011 Aug; 119(2-3):188-93. PubMed ID: 21679679
[TBL] [Abstract][Full Text] [Related]
33. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapeutic potential of Codonopsis clematidea and naringenin against visceral leishmaniasis.
Kaur G; Chauhan K; Kaur S
Biomed Pharmacother; 2018 Dec; 108():1048-1061. PubMed ID: 30372805
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
Asad M; Bhattacharya P; Banerjee A; Ali N
BMC Infect Dis; 2015 Apr; 15():188. PubMed ID: 25884796
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.
Thakur A; Kaur H; Kaur S
Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605
[TBL] [Abstract][Full Text] [Related]
37. Antileishmanial efficacy of Boerhaavia diffusa L. and Ocimum sanctum L. against experimental visceral leishmaniasis.
Kaur S; Bhardwaj K; Sachdeva H
Indian J Exp Biol; 2015 Aug; 53(8):522-9. PubMed ID: 26349315
[TBL] [Abstract][Full Text] [Related]
38. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
Mazumdar T; Anam K; Ali N
Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
[TBL] [Abstract][Full Text] [Related]
39. Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.
Das A; Jawed JJ; Das MC; Parveen S; Ghosh C; Majumdar S; Saha B; Bhattacharjee S
Cytokine; 2021 Jan; 137():155319. PubMed ID: 33002744
[TBL] [Abstract][Full Text] [Related]
40. Alcoholic Fractions F5 and F6 from
Chandrasekaran S; Veronica J; Sundar S; Maurya R
Front Med (Lausanne); 2017; 4():55. PubMed ID: 28553635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]